Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Tuesday, November 10, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 7
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ESMO Launches Clinical Trials Funding Initiative to Optimise Cancer Care Pathways
Ogkologos
-
September 10, 2026
0
Daraxonrasib Shows Antitumour Activity in Patients with Previously Treated Metastatic RAS-mutated...
Ogkologos
-
September 10, 2026
0
FDA Approves Gedatolisib with Fulvestrant, With or Without Palbociclib, for HR-positive,...
Ogkologos
-
September 9, 2026
0
Potential Role of an Activated Tumour Immune Microenvironment in Predicting Benefit...
Ogkologos
-
September 8, 2026
0
Perioperative Pembrolizumab Plus Neoadjuvant Chemotherapy Continues to Prolong EFS and OS...
Ogkologos
-
September 7, 2026
0
Patient Guide in Soft Tissue Sarcoma Now Available Also in Ukrainian
Ogkologos
-
September 4, 2026
0
ESMO Welcomes European Parliament (EP) report on Psychosocial Risks (PSR) at...
Ogkologos
-
September 3, 2026
0
Adjuvant Pembrolizumab Continues to Demonstrate Benefit in DFS and OS Among...
Ogkologos
-
September 3, 2026
0
FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic...
Ogkologos
-
September 2, 2026
0
ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research,...
Ogkologos
-
September 1, 2026
0
1
...
6
7
8
...
432
Page 7 of 432
MOST POPULAR
Cure Probability Models for Evaluation of Patients with a Previous Cancer...
October 26, 2021
EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib
November 27, 2024
EMA Recommends Granting a Marketing Authorisation for Tepotinib
December 23, 2021
Efficacy and Safety of Patritumab Deruxtecan in Patients with EGFR-mutated NSCLC...
September 29, 2023
Load more
HOT NEWS
Some Children with Liver Cancer May Need Less Chemotherapy, Study Suggests
Study Shows Thymic Health is Linked to Cancer Patients’ Response to...
FDA Grants Accelerated Approval to Talquetamab-tgvs for Relapsed or Refractory Multiple...
Νέα διαγνωστική μέθοδος για τον καρκίνο, με τη συμβολή της Microsoft
Ελληνικά
English (UK)